What is the current stock price of Alseres Pharmaceuticals, Inc. (ALSE)?

As of the latest market data, Alseres Pharmaceuticals, Inc. (ALSE) is trading at $0.01. The stock has seen a gain of 100.00% today.

Does Alseres Pharmaceuticals, Inc. (ALSE) pay a dividend?

Based on current data, Alseres Pharmaceuticals, Inc. does not have a confirmed active dividend policy.

What is the market cap of Alseres Pharmaceuticals, Inc.?

The current market capitalization of Alseres Pharmaceuticals, Inc. (ALSE) is approximately unavailable.

ALSE

Alseres Pharmaceuticals, Inc.·Healthcare

0.01

100.000%(+0.01)

Close Price

Last Updated: — ET

52W L: $0.0152W H: $0.01

ALSE NEWS

defenseworld.net

Mar 25

Financial Contrast: Alseres Pharmaceuticals (OTCMKTS:ALSE) vs. Relmada Therapeutics (NASDAQ:RLMD)

Relmada Therapeutics (NASDAQ: RLMD - Get Free Report) and Alseres Pharmaceuticals (OTCMKTS:ALSE - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations. Insider and Institutional Ownership 45.2% of Relmada Therapeutics

Company Profile

Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

1994-12-22

Beta

0.21

Websitewww.alseres.com↗